A real-world, multicenter real-cohort study assessing in treatment-failure to direct antiviral HCV regimens from the German hepatitis C registry (DHC-R)
Latest Information Update: 18 Jun 2020
At a glance
- Drugs Sofosbuvir/velpatasvir/voxilaprevir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
Most Recent Events
- 18 Jun 2020 New trial record